Cochrane is the only international organization that has the goal of synthesizing and keeping up to date the evidence for all of healthcare. Systematic reviews use explicit methods to identify, appraise, and synthesize available evidence for a clinical question. Cochrane Eyes and Vision (CEV) aims to prepare and promote access to systematic reviews of interventions used to prevent or treat eye conditions and/or visual impairment, and to help people adjust to visual impairment or blindness. For 17 years, CEV United States Satellite (CEV@US) has overseen production of systematic reviews contributing to eyes and vision comparative effectiveness research in the US in many ways. The purpose of comparative effectiveness research is to assist patients, clinicians, purchasers, and policy makers in making informed health decisions, and to contribute to evidence-based healthcare. Specifically, CEV@US aims to
CEV@US Faculty, Staff and Students
Tianjing Li, MD, MHS, PhD, serves as the Director for CEV@US.She is an Associate Professor in the Department of Ophthalmology at University of Colorado Anschutz Medical Campus with a secondary appointment in the Department of Epidemiology at University of Colorado School of Public Health.
Alison Su-Hsun Liu, MD, MPH, PhD, is a Research Assistant Professor at Department of Ophthalmology at University of Colorado Anschutz Medical Campus. Before joining the Cochrane Eye and Vision US Satellite (CEV@US) in July 2021, Alison was a consulting methodologist for CEV between February and June 2021. Meanwhile, Alison has been an Adjunct Assistant Professor of the International Health Program at National Yang Ming Chiao Tung University (formerly National Yang Ming University) since 2018. Dr. Liu received her MPH and PhD in epidemiology from Johns Hopkins Bloomberg School of Public Health and MD from National Taiwan University.
Renee F. Wilson, MS, is a Research Associate at the Johns Hopkins University School of Public Health. She has been the Managing Editor for the Cochrane Eye and Vision US Satellite (CEV@US) since 2018. Additionally, she
works with the Johns Hopkins University Evidence-based Practice Center (EPC) as a Senior Research Program Manager. Prior to this she was the Managing Editor for the Journal of General Internal medicine for five years.
Sueko Ng, MHS, is a methodologist with the Cochrane Eye and Vision US Satellite (CEV@US). Her role includes assisting the systematic review process, such as assessing the eligibility of relevant studies, critically appraising
risk of bias, extracting data, conducting qualitative and quantitative data synthesis, and preparing manuscripts for publication in The Cochrane Library. She received her Master of Health Science Degree from Johns Hopkins Bloomberg
School of Public Health.
|Louis Leslie, BA, is a research methodologist with Cochrane Eyes and Vision (CEV@US). His research background has involved qualitative, quantitative, and mixed methods. After preclinical training in medical school at the University
of Colorado, he transitioned to working on research in clinical ethics, evidence synthesis, and review methodology. As a methodologist at CEV@US, he assists review authors in performing Cochrane systematic reviews. |
Genie Han, MS, is a Senior Research Project Coordinator with the Cochrane Eye and Vision US Satellite (CEV@US). She has been involved with CEV@US since 2012. Ms. Han also serves as the coordinator for Consumers United
for Evidence-based Healthcare (CUE), a coalition of consumer health advocacy organizations in the United States.
Paul McCann, MBChB, MRes, PhD is a post-doctoral research fellow at the Department of Ophthalmology. Paul was awarded his PhD in Medicine from Queen’s University Belfast, UK. His doctoral research focused on applied
epidemiology and diagnostics in glaucoma. Prior to his PhD, Paul gained his Masters of Research in Translational Medicine from Queen’s University Belfast, UK and his medical degree from the University of Liverpool, UK. Paul will
be working with the CEV@US team as part of his post-doctoral fellowship at Colorado.
Riaz Qureshi, MSc, is a PhD Candidate at in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. Riaz's academic background includes a Bachelor of Science in public health and a Master of
Science in epidemiology and biostatistics from the universities of Waterloo and Western Ontario, respectively. Riaz's research focuses on the methods used to investigate harms of interventions at different levels of evidence: from
adverse events collected and reported in clinical trials to the synthesis of harms in systematic reviews.
Lin Wang, MHS, is a PhD candidate in the Department of Epidemiology at Johns Hopkins University Bloomberg School of Public Health. Lin worked for China Food and Drug Administration (FDA, now named National Medical
Products Administration) for four years as a medical reviewer and principal staff member. Lin’s academic background includes a ScM in Epidemiology from Johns Hopkins University Bloomberg School of Public Health and a MD from
Central South University Xiangya School of Medicine.
Barbara S. Hawkins, MS, PhD, FSCT
Roberta Scherer, PhD, MA
Kirk Wilhelmus, MD, MPH, PhD
CEV@US Personnel (past and present): Tianjing Li, Kay Dickersin, Roberta Scherer, Lori Rosman, Genie Han, Jimmy Le, Riaz Qureshi, Jiajun Wen, Kristina Lindsley, Sarah Money, Yuanxi Jia, and Kolade Fapohunda. Not pictured: Henry Jampel, Barbara Hawkins, Naira Khachatryan, Naresh Mandava, Alan Palestine, Ian Saldanha, Samuel Abariga, Renee Wilson, Sueko Ng, Lin Wang, Jianyu E, Nancy Fitton, and Claire Twose.